Cerebellar Hemangioblastoma in A Patient With Von Hippel-Lindau Syndrome
Julia Brasileiro de Faria Cavalcante, Pedro Nogarotto Cembraneli, Italo Nogarotto Cembraneli, Renata Brasileiro de Faria Cavalcante, José Edison da Silva Cavalcante, Leonardo Taveira Lopes, Alessandro Fonseca Cardoso, Chrystiano Fonseca Cardoso
Von Hippel-Lindau syndrome (VHL) is an autosomal dominant hereditary disease characterized by
a variety of benign/malignant tumors, mainly hemangioblastomas, renal, pancreatic, and hepatic
alterations, as well as pheochromocytoma. The disease is associated with high morbidity and mortality
and can affect multiple family members. Due to the potential for serious complications and psychosocial
impacts, early diagnosis is crucial for monitoring tumor lesions, multidisciplinary treatment, and
appropriate genetic counseling.
